Monday, January 7, 2019
Eli Lilly sees no change to dividend policy as a result of Loxo deal
Eli Lilly (LLY), on its conference call discussing its proposed $8B acquisition of Loxo Oncology (LOXO), said that it sees no change to dividend policy as a result of the deal, though it will limit share repurchases in 1H. The company said it expects modest downward pressure on margins in the near-term.
https://thefly.com/landingPageNews.php?id=2844661
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.